Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $9.56 billion. The enterprise value is $8.79 billion.
| Market Cap | 9.56B |
| Enterprise Value | 8.79B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 132.47 million shares outstanding. The number of shares has decreased by -0.58% in one year.
| Current Share Class | 110.04M |
| Shares Outstanding | 132.47M |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | -1.00% |
| Owned by Insiders (%) | 17.41% |
| Owned by Institutions (%) | 93.15% |
| Float | 109.13M |
Valuation Ratios
The trailing PE ratio is 17.77 and the forward PE ratio is 13.97. Globus Medical's PEG ratio is 1.08.
| PE Ratio | 17.77 |
| Forward PE | 13.97 |
| PS Ratio | 3.04 |
| Forward PS | 2.99 |
| PB Ratio | 2.00 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | 12.47 |
| P/OCF Ratio | 10.32 |
| PEG Ratio | 1.08 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.58, with an EV/FCF ratio of 11.47.
| EV / Earnings | 15.77 |
| EV / Sales | 2.80 |
| EV / EBITDA | 8.58 |
| EV / EBIT | 11.79 |
| EV / FCF | 11.47 |
Financial Position
The company has a current ratio of 4.30, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.30 |
| Quick Ratio | 2.44 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.13% and return on invested capital (ROIC) is 13.72%.
| Return on Equity (ROE) | 12.13% |
| Return on Assets (ROA) | 8.78% |
| Return on Invested Capital (ROIC) | 13.72% |
| Return on Capital Employed (ROCE) | 14.86% |
| Weighted Average Cost of Capital (WACC) | 9.37% |
| Revenue Per Employee | $523,268 |
| Profits Per Employee | $92,939 |
| Employee Count | 6,000 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.21 |
Taxes
In the past 12 months, Globus Medical has paid $141.76 million in taxes.
| Income Tax | 141.76M |
| Effective Tax Rate | 20.27% |
Stock Price Statistics
The stock price has decreased by -14.84% in the last 52 weeks. The beta is 0.95, so Globus Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | -14.84% |
| 50-Day Moving Average | 76.55 |
| 200-Day Moving Average | 82.70 |
| Relative Strength Index (RSI) | 41.67 |
| Average Volume (20 Days) | 2,008,841 |
Short Selling Information
The latest short interest is 9.46 million, so 7.14% of the outstanding shares have been sold short.
| Short Interest | 9.46M |
| Short Previous Month | 8.44M |
| Short % of Shares Out | 7.14% |
| Short % of Float | 8.66% |
| Short Ratio (days to cover) | 7.12 |
Income Statement
In the last 12 months, Globus Medical had revenue of $3.14 billion and earned $557.64 million in profits. Earnings per share was $4.06.
| Revenue | 3.14B |
| Gross Profit | 2.18B |
| Operating Income | 746.08M |
| Pretax Income | 699.39M |
| Net Income | 557.64M |
| EBITDA | 1.03B |
| EBIT | 746.08M |
| Earnings Per Share (EPS) | $4.06 |
Balance Sheet
The company has $871.17 million in cash and investments and $108.19 million in debt, with a net cash position of $762.99 million or $5.76 per share.
| Cash & Investments | 871.17M |
| Total Debt | 108.19M |
| Net Cash | 762.99M |
| Net Cash Per Share | $5.76 |
| Equity (Book Value) | 4.80B |
| Book Value Per Share | 36.15 |
| Working Capital | 1.67B |
Cash Flow
In the last 12 months, operating cash flow was $925.92 million and capital expenditures -$159.37 million, giving a free cash flow of $766.55 million.
| Operating Cash Flow | 925.92M |
| Capital Expenditures | -159.37M |
| Depreciation & Amortization | 279.22M |
| Net Borrowing | n/a |
| Free Cash Flow | 766.55M |
| FCF Per Share | $5.79 |
Margins
Gross margin is 69.33%, with operating and profit margins of 23.76% and 17.76%.
| Gross Margin | 69.33% |
| Operating Margin | 23.76% |
| Pretax Margin | 22.28% |
| Profit Margin | 17.76% |
| EBITDA Margin | 32.66% |
| EBIT Margin | 23.76% |
| FCF Margin | 24.42% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.58% |
| Shareholder Yield | 0.58% |
| Earnings Yield | 5.63% |
| FCF Yield | 8.02% |
Analyst Forecast
The average price target for Globus Medical is $93.43, which is 29.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $93.43 |
| Price Target Difference | 29.51% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 5.58% |
| EPS Growth Forecast (3Y) | 13.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 10.86 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.86 |
| Piotroski F-Score | 7 |